China, Aug. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective, single-arm, multi-center real-world study on the safety and efficacy of acsimethine sustained-release capsules in the treatment of low back pain'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130633

Registration Time: 2026/08/22

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital of Zhengzhou University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337630

Published by HT Digital Content Services with permission from Health Daily Digest....